Cargando…
Lithium-Associated Hypercalcemia Presenting with Neuropsychiatric Manifestations in a Patient with Bipolar Disorder
One of the overlooked adverse effects of lithium treatment is neuropsychiatric manifestations induced by hypercalcemia (LAH). Here, we present the case of a patient, with bipolar disorder under lithium, who presented with neuropsychiatric symptoms that revealed hyperparathyroidism-induced hypercalce...
Autores principales: | Benjelloun, Roukaya, Motaib, Imane, Otheman, Yassine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7787858/ https://www.ncbi.nlm.nih.gov/pubmed/33457034 http://dx.doi.org/10.1155/2020/6630838 |
Ejemplares similares
-
Psychiatric side effects of chloroquine in COVID-19 patients: two case reports
por: Benjelloun, Roukaya, et al.
Publicado: (2020) -
Major depressive disorder: Validated treatments and future challenges
por: Karrouri, Rabie, et al.
Publicado: (2021) -
Consultation liaison psychiatry for COVID-19 inpatients: A novel care delivery program in Morocco
por: Benjelloun, Roukaya, et al.
Publicado: (2020) -
Lithium-induced Symptomatic Hypercalcemia and Hyperparathyroidism in a Patient with Bipolar Affective Disorder: A Case Report and Review of Literature
por: Pamathy, Gnanaselvam, et al.
Publicado: (2018) -
Hypercalcemia as a Presenting Clinical Manifestation of Adenocarcinoma of the Colon
por: Argento, Angelo
Publicado: (2012)